NCT06904404View on ClinicalTrials.gov

Physiologic Phacofluidics: Ghost Protocol

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
Cataract
Interventions
PROCEDURE

Cataract surgery at high IOP

Cataract surgery at high IOP (conventional)

PROCEDURE

Cataract surgery at low IOP

Cataract surgery at low IOP

Trial Locations (1)

52233

Wolfe Eye Clinic Cedar Rapids (Hiawatha), Hiawatha

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Wolfe Eye Clinic

OTHER

NCT06904404 - Physiologic Phacofluidics: Ghost Protocol | Biotech Hunter | Biotech Hunter